Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics-Reference-Cited by-同舟云学术

Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics

Published:2015-04-13 Issue:7 Volume:43 Page:1028-1036
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Kus Kamil,Walczak Maria,Maslak Edyta,Zakrzewska Agnieszka,Gonciarz-Dytman Anna,Zabielski Piotr,Sitek Barbara,Wandzel Krystyna,Kij Agnieszka,Chabowski Adrian,Holland Ryan J.,Saavedra Joseph E.,Keefer Larry K.,Chlopicki Stefan

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference64 articles.

1. A Cyclic Guanosine Monophosphate–Dependent Pathway Can Regulate Net Hepatic Glucose Uptake in Vivo

2. Liver X receptor agonist T0901317 enhanced peroxisome proliferator-activated receptor-delta expression and fatty acid oxidation in rat skeletal muscle;Baranowski;J Physiol Pharmacol,2013

3. Role of nitric oxide in liver regeneration;Carnovale;Ann Hepatol,2012

4. V-PROLI/NO, a Prodrug of the Nitric Oxide Donor, PROLI/NO

5. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice;Cook;Swiss Med Wkly,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Components of Buyang Huanwu Decoction with UPLC-MS;Natural Product Communications;2024-09

2. Gasotransmitters in non-alcoholic fatty liver disease: just the tip of the iceberg;European Journal of Pharmacology;2023-09

3. Long-Term Effects of Aircraft Noise Exposure on Vascular Oxidative Stress, Endothelial Function and Blood Pressure: No Evidence for Adaptation or Tolerance Development;Frontiers in Molecular Biosciences;2022-01-31

4. L‐ornithine L ‐aspartate in acute treatment of severe hepatic encephalopathy: A double‐blind randomized controlled trial;Hepatology;2021-12-21

5. Organosilica colloids as nitric oxide carriers: Pharmacokinetics and biocompatibility;Colloids and Surfaces B: Biointerfaces;2021-12